Dr. Omri Amirav-Drory is a General Partner at NFX whose mission in life is to end involuntary death. Omri has backed companies like Mammoth Biosciences, Immunai, and Centivax, and has earned a reputation as one of the most respected seed investors in tech-enabled life sciences and longevity. He previously founded Genome Compiler and sold it to Twist Bioscience, which is now worth $2.5 billion. We’ll talk about why longevity research could solve America's biggest economic problems, Omri’s 4 step ABCD plan for beating death, and why AI alone won’t solve aging.

Dr. Jacob Kimmel is the President of NewLimit, a biotechnology company developing reprogramming medicines to treat age-related disease and extend human healthspan. Dr. Kimmel co-founded the company with Blake Byers and Bryan Armstrong, and has since raised over $300M from top venture capital funds like Kleiner Perkins, Dimension, Founders Fund, and Khosla Ventures. They expect to initiate their first clinical trial in a few years.

Dr. Kimmel has garnered a reputation as one of the brightest minds in longevity and the intersection between artificial intelligence and molecular biology, and NewLimit is often cited as one of the most important companies building in longevity today.

Adam Gries is a serial entrepreneur with four successful exits, and products that have reached over eighty million users. He has now set his sights on creating a longevity revolution through his organization Vitalism. Vitalism is a moral philosophy and community of action, forming a revolutionary movement to get humanity to fight as hard as possible to achieve unlimited lifespans in peak health.

Our conversation covers the state of the longevity field today, the myth of billionaires’ obsession with longevity, what it will take to revolutionize our culture and industry to treat aging seriously, and much more.